Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating aplastic anemia caused by spleen-kidney yang deficiency

A technique for aplastic and spleen-kidney yang-deficiency types, which can be used in drug combinations, blood diseases, and pharmaceutical formulations, and can solve problems such as unsatisfactory therapeutic effects, severe adverse reactions, and difficulty in long-term application

Inactive Publication Date: 2017-06-13
钱建荣
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Drugs for the treatment of aplastic anemia are expensive, costly and unsatisfactory
Modern medicine generally uses blood transfusion therapy combined with western medicine to treat aplastic anemia of spleen and kidney yang deficiency, but the adverse reactions are serious and it is difficult to use it for a long time

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0067] A pharmaceutical composition for treating aplastic anemia of spleen-kidney yang deficiency type, which is prepared from the following raw materials: 10 parts of ginseng, 20 parts of sword bark, 20 parts of Ganoderma lucidum, 12 parts of Astragalus, 15 parts of Atractylodes Rhizoma, 12 parts of Rehmannia, 12 parts of Chinese yam, 15 parts of dogwood, 15 parts of dodder, 8 parts of Morinda officinalis, 8 parts of psoralen, 20 parts of Cistanche, 10 parts of tea tree root, 35 parts of black bean skin, 12 parts of angelica, 8 parts of cinnamon, 15 parts of antler gum, 15 parts of kidney grass, 10 parts of Hedyotis diffusa, and 6 parts of two-color tonic grass.

Embodiment 2

[0069] A medicinal composition for treating aplastic anemia of spleen-kidney yang deficiency type, which is made from the following raw materials: 25 parts of ginseng, 30 parts of scabbard fungus, 35 parts of ganoderma lucidum, 22 parts of astragalus, 20 parts of Atractylodes Rhizoma, 22 parts of Rehmannia, 22 parts of yam, 25 parts of dogwood, 22 parts of dodder, 15 parts of Morinda officinalis, 16 parts of psoralen, 30 parts of Cistanche, 20 parts of tea tree root, 50 parts of black bean skin, 25 parts of angelica, 12 parts of cinnamon, 25 parts of antler gum, 25 parts of kidney grass, 20 parts of Hedyotis diffusa, 18 parts of two-color tonic grass.

Embodiment 3

[0071] A pharmaceutical composition for treating aplastic anemia of spleen-kidney yang deficiency type, which is prepared from the following raw materials: 22 parts of ginseng, 25 parts of sword bark, 30 parts of Ganoderma lucidum, 16 parts of Astragalus, 16 parts of Atractylodes Rhizoma, 16 parts of Rehmannia, 16 parts of yam, 22 parts of dogwood, 18 parts of dodder, 12 parts of Morinda officinalis, 12 parts of psoralen, 25 parts of Cistanche, 16 parts of tea tree root, 45 parts of black bean skin, 22 parts of angelica, 9 parts of cinnamon, 22 parts of antler gum, 22 parts of kidney grass, 15 parts of Hedyotis diffusa, and 12 parts of two-color tonic grass.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a pharmaceutical composition for treating aplastic anemia caused by spleen-kidney yang deficiency. The pharmaceutical composition is prepared from the following crude drugs in parts by weight: 10-25 parts of ginseng, 20-30 parts of phellinus torulosus, 20-35 parts of ganoderma lucidum, 12-22 parts of astragalus membranaceus, 15-20 parts of rhizoma atractylodis macrocephalae, 12-22 parts of radix rehmanniae preparata, 12-22 parts of Chinese yam, 15-25 parts of dogwood, 15-22 parts of semen cuscutae, 8-15 parts of morinda officinalis, 8-16 parts of fructus psoraleae, 20-30 parts of cistanche, 10-20 parts of tea tree roots, 35-50 parts of black bean peel, 12-25 parts of angelica sinensis, 8-12 parts of cinnamon, 15-25 parts of deer-horn glue, 15-25 parts of all-grass of lance lerminium, 10-20 parts of oldenlandia diffusa and 6-18 parts of limonium bicolor. The invention aims at providing the pharmaceutical composition which is good in treatment effect, high in effective rate and free of toxic or side effect in human body for treating aplastic anemia caused by spleen-kidney yang deficiency.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating aplastic anemia of spleen-kidney yang deficiency type. Background technique [0002] Aplastic anemia (AA, aplastic anemia) is a bone marrow hematopoietic failure disease, mainly manifested as bone marrow hematopoietic hypofunction, pancytopenia and anemia, bleeding, infection syndrome. The main clinical manifestations are anemia, bleeding and infection. Aplastic anemia belongs to the categories of "consumption of labor" and "blood blood" in traditional Chinese medicine. The main symptoms are anemia, bleeding, infection, and fever are mild. [0003] Western medicine has not fully elucidated the etiology and difficult to treat. Traditional therapy requires regular blood transfusion, fluid infusion and hospitalization. The cure rate is low, and the economic burden is heavy, which brings pain to patients and their families and loses confidenc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/898A61P7/00A61P7/06A61K35/32
CPCA61K36/898A61K35/32A61K36/07A61K36/074A61K36/185A61K36/232A61K36/258A61K36/284A61K36/39A61K36/40A61K36/43A61K36/48A61K36/481A61K36/487A61K36/54A61K36/64A61K36/746A61K36/748A61K36/804A61K36/82A61K36/8945A61K2300/00
Inventor 钱建荣
Owner 钱建荣
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com